Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 3Phase 1 2Phase 4 1Phase 3 1

Status

Completed 24Unknown 6Terminated 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 192Neoplasms 147Prostatic Neoplasms 101Lung Neoplasms 90Carcinoma, Non-Small-Cell Lung 62Colorectal Neoplasms 59Head and Neck Neoplasms 52Pancreatic Neoplasms 46Carcinoma, Hepatocellular 44Rectal Neoplasms 42Brain Neoplasms 41Multiple Myeloma 39Colonic Neoplasms 37Esophageal Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 30Leukemia, Myeloid, Acute 30Ovarian Neoplasms 29Lymphoma, Non-Hodgkin 29Leukemia 29Lymphoma 28Motor Activity 25Hodgkin Disease 24Uterine Cervical Neoplasms 23Carcinoma, Renal Cell 23Pain 22Lymphoma, Follicular 22Depression 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioma 21

Interventions

Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Terminated × COVID-19 × Clear all
NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Scripps Translational Science Institute

Phase NA Terminated
2,117 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT04805203 2023-10-19

Covimmunomm

Intergroupe Francophone du Myelome

Phase NA Terminated
139 enrolled
Plasma cell

COVID-19, Multiple Myeloma

NCT04726163 2022-04-27

COVIDEX

University Hospital, Strasbourg, France

Phase NA Terminated
48 enrolled

COVID-19, Diabetes Mellitus, Diabetes Mellitus, Type 2, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡